79399473

Information

• Trademark
• 79399473

• Source

• Serial Number

  79399473

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  May 02, 2024
  7 months ago

• Transaction Date

  November 26, 2024
  3 days ago

• Status Date

  November 25, 2024
  4 days ago

• Location Date

  November 25, 2024
  4 days ago

• Status Code

  640

• Current Location

  TMO LAW OFFICE 123

  Employee Name

  BERGER, MAGDALENA

• Attorney Docket Number

  599729

  Attorney Name

  Andrew D. Price

  Law Office Assigned Location Code

  N50

• Owners

  • BicycleTx Limited

Case File Statements

• GS0051: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.
• GS0441: Medical services; medical testing; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid.
• GS0421: Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.

Case File Event Statements

• 7/11/2024 - 4 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 7/12/2024 - 4 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/12/2024 - 4 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/19/2024 - 2 months ago

  7 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 9/19/2024 - 2 months ago

  8 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 9/19/2024 - 2 months ago

  6 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 9/19/2024 - 2 months ago

  5 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 9/19/2024 - 2 months ago

  4 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 11/16/2024 - 13 days ago

  9 - ASSIGNED TO EXAMINER Type: DOCK

• 11/26/2024 - 3 days ago

  11 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 11/25/2024 - 4 days ago

  10 - NON-FINAL ACTION WRITTEN Type: CNRT